Compare STOK & ALKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | ALKT |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2019 | 2021 |
| Metric | STOK | ALKT |
|---|---|---|
| Price | $30.79 | $18.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $39.20 | $28.57 |
| AVG Volume (30 Days) | 469.0K | ★ 1.6M |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.73 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $184,420,000.00 | $152,159,000.00 |
| Revenue This Year | N/A | $21.85 |
| Revenue Next Year | $77.49 | $16.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 404.50 | 35.68 |
| 52 Week Low | $9.47 | $14.11 |
| 52 Week High | $40.22 | $31.18 |
| Indicator | STOK | ALKT |
|---|---|---|
| Relative Strength Index (RSI) | 44.04 | 63.81 |
| Support Level | $30.34 | $15.16 |
| Resistance Level | $35.11 | $19.21 |
| Average True Range (ATR) | 1.49 | 0.79 |
| MACD | 0.10 | 0.11 |
| Stochastic Oscillator | 43.44 | 84.52 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.